Kestra Medical Technologies Files IPO Amendment
Ticker: KMTS · Form: S-1/A · Filed: Feb 26, 2025 · CIK: 1877184
| Field | Detail |
|---|---|
| Company | Kestra Medical Technologies, LTD. (KMTS) |
| Form Type | S-1/A |
| Filed Date | Feb 26, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: ipo, medical-devices, sec-filing
TL;DR
Kestra Medical IPO filing updated. Get ready for a new medical tech player.
AI Summary
Kestra Medical Technologies, Ltd. filed an S-1/A amendment on February 26, 2025, for its initial public offering. The company, incorporated in Bermuda with principal executive offices in Kirkland, Washington, is registering an unspecified number of securities under the Securities Act of 1933. The filing details their business operations and financial information as they prepare to become a publicly traded entity.
Why It Matters
This S-1/A filing indicates Kestra Medical Technologies is moving forward with its plan to become a publicly traded company, which could lead to increased investment and market presence.
Risk Assessment
Risk Level: medium — As an S-1/A filing for an IPO, the company is still in the process of going public, meaning its future financial performance and market acceptance are not yet established.
Key Numbers
- 3841 — SIC Code (Standard Industrial Classification for Surgical & Medical Instruments & Apparatus)
Key Players & Entities
- KESTRA MEDICAL TECHNOLOGIES, LTD. (company) — Registrant
- February 26, 2025 (date) — Filing Date
- 333-284807 (registration_number) — SEC File Number
- Brian Webster (person) — Chief Executive Officer
- Sophia Hudson, P.C. (company) — Legal Counsel
- Christie W.S. Mok (person) — Legal Counsel
FAQ
What is the primary business of Kestra Medical Technologies, Ltd.?
The filing indicates Kestra Medical Technologies, Ltd. is in the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' industry, SIC code 3841.
When was this amendment to the S-1 filing submitted?
This amendment (S-1/A) was filed with the SEC on February 26, 2025.
Where are Kestra Medical Technologies' principal executive offices located?
The principal executive offices are located at 3933 Lake Washington Blvd NE, Suite 200, Kirkland, Washington 98033.
Who is the Chief Executive Officer of Kestra Medical Technologies?
Brian Webster is listed as the Chief Executive Officer.
What is the SEC file number for this registration statement?
The SEC file number is 333-284807.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on February 26, 2025 by Brian Webster regarding KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS).